Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001967722-23-000005
Filing Date
2023-03-09
Accepted
2023-03-09 18:26:34
Documents
3
Period of Report
2023-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_167840438290862.html 3  
1 FORM 3 wf-form3_167840438290862.xml 3 1712
2 POWER OF ATTORNEY krystal-section16poamazz.htm EX-24 3609
3 POWER OF ATTORNEY krystal-section16poamazz001.jpg GRAPHIC 228921
  Complete submission text file 0001967722-23-000005.txt   322142
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Issuer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203
Business Address
Mazzacco Catherine (Reporting) CIK: 0001967722 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38210 | Film No.: 23721098